Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for sanofi aventis in registrations and monthly communication reports

Refine registrations results by

Status Type Subject matter Government institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (234)
Results: 1-50 | Export
  1. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 14 of 14 (2024-01-09 to present)
    Posted: 2024-01-09
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  2. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 8 of 8 (2024-01-08 to present)
    Posted: 2024-01-09
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  3. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 13 of 14 (2024-01-08 to 2024-01-09)
    Posted: 2024-01-09
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  4. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 12 of 14 (2023-12-20 to 2024-01-08)
    Posted: 2023-12-21
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  5. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)
    Registration: 40 of 40 (2023-09-01 to present)
    Posted: 2023-09-01
    Subject matter details: 10
    Government institutions: 19
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  6. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 6 of 6 (2023-06-27 to present)
    Posted: 2023-09-18
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  7. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 5 of 6 (2023-04-01 to 2023-06-27)
    Posted: 2023-04-03
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  8. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)
    Registration: 39 of 40 (2023-03-16 to 2023-09-01)
    Posted: 2023-03-16
    Subject matter details: 10
    Government institutions: 19
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  9. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 11 of 14 (2022-11-14 to 2023-12-20)
    Posted: 2022-11-17
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  10. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 8 of 8 (2022-11-14 to 2023-09-15)
    Posted: 2022-11-17
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  11. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 7 of 8 (2022-11-14 to 2024-01-08)
    Posted: 2022-11-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  12. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 7 of 8 (2022-10-14 to 2022-11-14)
    Posted: 2022-10-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  13. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 4 of 6 (2022-10-11 to 2023-04-01)
    Posted: 2022-10-13
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  14. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)
    Registration: 38 of 40 (2022-10-03 to 2023-03-16)
    Posted: 2022-10-04
    Subject matter details: 10
    Government institutions: 19
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  15. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 6 of 8 (2022-05-16 to 2022-10-14)
    Posted: 2022-05-17
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  16. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 10 of 14 (2022-04-22 to 2022-11-14)
    Posted: 2022-04-25
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  17. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 6 of 8 (2022-04-22 to 2022-11-14)
    Posted: 2022-04-25
    Subject matter details: 9
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  18. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 5 of 8 (2022-02-28 to 2022-04-22)
    Posted: 2022-02-28
    Subject matter details: 9
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  19. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)
    Registration: 37 of 40 (2022-02-25 to 2022-10-03)
    Posted: 2022-04-04
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  20. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 3 of 6 (2021-12-20 to 2022-10-11)
    Posted: 2021-12-20
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  21. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Carrie McElroy, President and Chief Executive Officer (CEO)
    Registration: 36 of 40 (2021-09-16 to 2022-02-25)
    Posted: 2021-09-17
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  22. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 4 of 8 (2021-04-16 to 2022-02-28)
    Posted: 2021-04-16
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  23. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 2 of 6 (2021-03-20 to 2021-12-20)
    Posted: 2021-04-08
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  24. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Registration: 1 of 6 (2021-03-12 to 2021-03-20)
    Posted: 2021-03-15
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  25. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 5 of 8 (2021-02-04 to 2022-05-16)
    Posted: 2021-03-03
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  26. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 3 of 8 (2020-11-10 to 2021-04-16)
    Posted: 2020-11-12
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  27. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 4 of 8 (2020-11-09 to 2021-02-04)
    Posted: 2020-11-12
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  28. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 9 of 14 (2020-11-09 to 2022-04-22)
    Posted: 2020-11-12
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  29. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Johanne Chambers, 3Sixty Public Affairs Inc.
    Registration: 3 of 8 (2020-10-06 to 2020-11-09)
    Posted: 2020-10-06
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  30. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 2 of 8 (2020-10-06 to 2020-11-10)
    Posted: 2020-10-06
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  31. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 8 of 14 (2020-10-06 to 2020-11-09)
    Posted: 2020-10-06
    Subject matter details: 8
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  32. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Marissa Poole, President and Chief Executive Officer (CEO)
    Registration: 35 of 40 (2020-09-17 to 2021-09-16)
    Posted: 2020-10-05
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  33. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Niven Al-Khoury, President and Chief Executive Officer (CEO)
    Registration: 34 of 40 (2020-04-14 to 2020-09-17)
    Posted: 2020-04-15
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  34. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Niven Al-Khoury, President and Chief Executive Officer (CEO)
    Registration: 33 of 40 (2019-10-16 to 2020-04-14)
    Posted: 2019-10-16
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  35. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Lucas Veiga, The Capital Hill Group
    Registration: 1 of 1 (2019-08-30 to 2020-05-15)
    Posted: 2019-09-03
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  36. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Nancy Cruz, The Capital Hill Group / Le Groupe Capital Hill
    Registration: 1 of 1 (2019-05-16 to 2019-08-30)
    Posted: 2019-05-21
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  37. Sanofi Pasteur
    Type: Consultant
    Lobbyist: DAVID ANGUS, The Capital Hill Group Inc.
    Registration: 2 of 2 (2019-04-25 to present)
    Posted: 2019-04-29
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  38. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Niven Al-Khoury, President and Chief Executive Officer (CEO)
    Registration: 32 of 40 (2019-04-13 to 2019-10-16)
    Posted: 2019-04-15
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  39. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Elaine Larsen Wells, Capital Hill Group
    Registration: 3 of 3 (2019-04-01 to 2019-05-17)
    Posted: 2019-04-10
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  40. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Elaine Larsen Wells, Capital Hill Group
    Registration: 2 of 3 (2018-05-16 to 2019-04-01)
    Posted: 2018-05-18
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  41. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Dan Mader, NATIONAL Public Relations
    Registration: 2 of 2 (2018-03-05 to 2018-04-20)
    Posted: 2018-03-13
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  42. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Dan Mader, NATIONAL Public Relations
    Registration: 1 of 2 (2017-09-29 to 2018-01-15)
    Posted: 2017-10-02
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  43. SANOFI AVENTIS CANADA
    Type: Consultant
    Lobbyist: Stephen Sampson, Global Public Affairs
    Registration: 9 of 9 (2017-06-01 to 2023-02-28)
    Posted: 2017-06-07
    Subject matter details: 13
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  44. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Niven Al-Khoury, President and Chief Executive Officer (CEO)
    Registration: 31 of 40 (2017-05-31 to 2019-04-13)
    Posted: 2017-05-31
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  45. Sanofi Pasteur
    Type: Consultant
    Lobbyist: NANCI WOODS, The Capital Hill Group
    Registration: 23 of 23 (2017-01-23 to 2019-02-28)
    Posted: 2017-01-23
    Subject matter details: 3
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
  46. SANOFI AVENTIS CANADA
    Type: Consultant
    Lobbyist: Stephen Sampson, Global Public Affairs
    Registration: 8 of 9 (2016-12-21 to 2017-06-01)
    Posted: 2016-12-21
    Subject matter details: 13
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  47. Sanofi Canada
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Registration: 8 of 8 (2016-12-14 to 2018-01-15)
    Posted: 2016-12-19
    Subject matter details: 6
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  48. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Responsible officer: Niven Al-Khoury, President and Chief Executive Officer (CEO)
    Registration: 30 of 40 (2016-10-03 to 2017-05-31)
    Posted: 2016-10-17
    Subject matter details: 10
    Government institutions: 20
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 4
  49. Sanofi Pasteur
    Type: Consultant
    Lobbyist: Elaine Larsen Wells, Capital Hill Group
    Registration: 1 of 3 (2016-09-19 to 2018-05-16)
    Posted: 2016-09-21
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  50. Sanofi Pasteur
    Type: Consultant
    Lobbyist: NANCI WOODS, The Capital Hill Group
    Registration: 22 of 23 (2016-08-18 to 2017-01-23)
    Posted: 2016-08-22
    Subject matter details: 5
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
Monthly communication reports (126)
Results: 1-50 | Export
  1. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-03-21
    Posted: 2016-04-20
    Designated public office holders:
    • Scott Simms, Député | House of Commons
    Subject matters:
    • International Relations
    • Science and Technology
    • Health
    • Intellectual Property
    • International Trade
    • Research and Development
      •
  2. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-03-15
    Posted: 2016-04-20
    Designated public office holders:
    • David Lametti, Député | House of Commons
    Subject matters:
    • International Relations
    • International Trade
    • Health
    • Intellectual Property
    • Science and Technology
      •
  3. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-03-08
    Posted: 2016-04-20
    Designated public office holders:
    • Mark Schaan, Directeur Général, Innovation, Sciences et Développement Économique Canada | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • International Trade
    • Health
    • Research and Development
    • Intellectual Property
    • International Relations
      •
  4. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-03-03
    Posted: 2016-03-15
    Designated public office holders:
    • Chrystia Freeland, Minister, International Trade | Global Affairs Canada (GAC)
    Subject matters:
    • Intellectual Property
    • Research and Development
    • Industry
    • International Relations
    • Health
    • Science and Technology
      •
  5. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-03-03
    Posted: 2016-04-20
    Designated public office holders:
    • Chrystia Freeland, Ministre, Commerce international | Global Affairs Canada (GAC)
    Subject matters:
    • Research and Development
    • International Trade
    • International Relations
    • Intellectual Property
    • Science and Technology
      •
  6. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-02-25
    Posted: 2016-03-15
    Designated public office holders:
    • Colin Fraser, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • International Trade
    • Health
    • Research and Development
    • Intellectual Property
      •
  7. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-02-18
    Posted: 2016-03-15
    Designated public office holders:
    • David Lametti, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Research and Development
    • Science and Technology
    • Health
    • International Trade
      •
  8. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-01-27
    Posted: 2016-02-22
    Designated public office holders:
    • Jacques Gourde, député | House of Commons
    Subject matters:
    • Intellectual Property
    • Health
    • Research and Development
    • Science and Technology
      •
  9. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-01-26
    Posted: 2016-02-22
    Designated public office holders:
    • Angelo Iacono, député | House of Commons
    • Faycal El-Khoury, député | House of Commons
    Subject matters:
    • Intellectual Property
    • Research and Development
    • Science and Technology
      •
  10. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-01-25
    Posted: 2016-02-22
    Designated public office holders:
    • François Philippe Champagne, Secrétaire parlementaire | Finance Canada (FIN)
    • Sylvie Boucher, député | House of Commons
    Subject matters:
    • Intellectual Property
    • International Relations
      •
  11. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-06-03
    Posted: 2015-07-15
    Designated public office holders:
    • Mario Lavoie, Directeur des Opérations, Infrastructure, Collectivités et Affaires gouvernementales | Infrastructure Canada (INFC)
    Subject matters:
    • Industry
    • Intellectual Property
      •
  12. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-06-02
    Posted: 2015-07-15
    Designated public office holders:
    • Marc Aurele Fortin, député | House of Commons
    Subject matters:
    • Intellectual Property
      •
  13. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-06-02
    Posted: 2015-07-15
    Designated public office holders:
    • Francois Pilon, député | House of Commons
    Subject matters:
    • Intellectual Property
      •
  14. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-03-11
    Posted: 2015-04-29
    Designated public office holders:
    • Rahul Bedi, Attaché politique | Treasury Board Of Canada Secretariat (TBS)
    Subject matters:
    • Intellectual Property
      •
  15. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-03-05
    Posted: 2015-04-29
    Designated public office holders:
    • Francois Desmarais, Attaché politique | Industry Canada
    Subject matters:
    • Intellectual Property
      •
  16. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-02-24
    Posted: 2015-03-18
    Designated public office holders:
    • François Lapointe, Dépuité, Chambre des communes | House of Commons
    Subject matters:
    • Health
    • Science and Technology
    • Intellectual Property
    • Research and Development
      •
  17. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-02-05
    Posted: 2015-03-18
    Designated public office holders:
    • François Lapointe, Député, Chambre des communies | House of Commons
    Subject matters:
    • Health
    • Intellectual Property
    • Science and Technology
    • Research and Development
      •
  18. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-02-05
    Posted: 2015-03-18
    Designated public office holders:
    • François Desmarais, Attaché politique du Ministre de l'Industrie, Industrie Canada | Industry Canada
    Subject matters:
    • Health
      •
  19. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-02-02
    Posted: 2015-03-18
    Designated public office holders:
    • Philip Jennings, Sous-ministre adjoint, Industrie Canada | Industry Canada
    Subject matters:
    • Research and Development
    • Science and Technology
    • Intellectual Property
      •
  20. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-01-27
    Posted: 2015-02-24
    Designated public office holders:
    • Chrystia Freeland, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Research and Development
    • Intellectual Property
      •
  21. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2015-01-27
    Posted: 2015-02-24
    Designated public office holders:
    • Don Davis, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Science and Technology
    • Research and Development
      •
  22. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-11-05
    Posted: 2014-12-21
    Designated public office holders:
    • François Lapointe, Député, Chambre des communes | House of Commons
    Subject matters:
    • Health
      •
  23. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-07-17
    Posted: 2014-08-15
    Designated public office holders:
    • Supriya Sharma, Sous-ministre adjointe déléguée intérimaire | Health Canada (HC)
    Subject matters:
    • Health
      •
  24. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-06-25
    Posted: 2014-07-23
    Designated public office holders:
    • Marion Lavoie, Attaché politique ministre Infrastructure, Collectivités et Affaires Gouv. | House of Commons
    Subject matters:
    • Research and Development
    • Intellectual Property
    • Science and Technology
    • Health
      •
  25. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-06-20
    Posted: 2014-07-23
    Designated public office holders:
    • Maurice Rioux, Attaché politique du député de Bourassa | House of Commons
    Subject matters:
    • Intellectual Property
    • Health
    • Science and Technology
    • Research and Development
      •
  26. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-06-13
    Posted: 2014-07-23
    Designated public office holders:
    • Maurice Rioux, Attaché politique du député de Bourassa | House of Commons
    Subject matters:
    • Health
    • Intellectual Property
    • Science and Technology
      •
  27. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-05-12
    Posted: 2014-06-26
    Designated public office holders:
    • Terence Young, Member of Parliament | House of Commons
    • Francois Pilon, Member of Parliament | House of Commons
    • Carol Hughes, Member of Parliament | House of Commons
    • Hedy Fry, Member of Parliament | House of Commons
    • Rob Merryfield, Member of Parliament | House of Commons
    • Kirsty Duncan, Member of Parliament | House of Commons
    • Kelvin Ogilvie, Member of Parliament | House of Commons
    Subject matters:
    • Intellectual Property
    • Research and Development
    • Science and Technology
      •
  28. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-05-01
    Posted: 2014-06-26
    Designated public office holders:
    • Carol Hughes, Member of Parliament, House of Commons | House of Commons
    Subject matters:
    • Science and Technology
    • Research and Development
    • Intellectual Property
      •
  29. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-04-30
    Posted: 2014-05-31
    Designated public office holders:
    • Kelvin Ogilvie, Sénateur, Sénat du Canada | Senate of Canada
    Subject matters:
    • Science and Technology
    • Research and Development
      •
  30. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-02-28
    Posted: 2014-03-19
    Designated public office holders:
    • Stephen Harper, Premier ministre | Prime Minister's Office (PMO)
    Subject matters:
    • Intellectual Property
    • International Trade
    • International Relations
    • Research and Development
      •
  31. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-02-19
    Posted: 2014-03-18
    Designated public office holders:
    • Francois Pilon, Député, Opposition | House of Commons
    • Alain Giguère, Député, Opposition | House of Commons
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
      •
  32. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-02-18
    Posted: 2014-03-18
    Designated public office holders:
    • Phelip Jennings, Sous-ministre associé | Industry Canada
    Subject matters:
    • Research and Development
    • Health
    • Science and Technology
      •
  33. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2014-02-10
    Posted: 2014-03-18
    Designated public office holders:
    • Francois Lapointe, Député | House of Commons
    Subject matters:
    • Science and Technology
    • Research and Development
    • Health
      •
  34. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2013-12-10
    Posted: 2014-01-23
    Designated public office holders:
    • Alain Giguère, Député, Chambre des Communes (Opposition) | House of Commons
    Subject matters:
    • Research and Development
    • Science and Technology
      •
  35. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2013-12-09
    Posted: 2014-01-23
    Designated public office holders:
    • François Pilon, Député, Chambre des Communes (Opposition) | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Science and Technology
    • Research and Development
      •
  36. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2013-12-04
    Posted: 2014-01-23
    Designated public office holders:
    • François Lapointe, Député, Chambre des Communes (Opposition) | House of Commons
    Subject matters:
    • Research and Development
    • Science and Technology
      •
  37. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-11-19
    Posted: 2012-12-20
    Designated public office holders:
    • Philip Jennings, Assistant Deputy Minister, Industrie Canada | Industry Canada
    Subject matters:
    • Research and Development
      •
  38. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-10-24
    Posted: 2012-11-20
    Designated public office holders:
    • John Patrick Stewart, Actiing Senrio Executive Director, Therapeutic Products Directorate | Health Canada (HC)
    Subject matters:
    • Health
      •
  39. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-10-19
    Posted: 2012-11-20
    Designated public office holders:
    • Francois Pilon, Member of the House of Commons | House of Commons
    Subject matters:
    • Research and Development
    • Science and Technology
      •
  40. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-10-18
    Posted: 2012-11-20
    Designated public office holders:
    • Rosane Doré, Député | House of Commons
    • Alain Giguère, Député | House of Commons
    Subject matters:
    • Research and Development
    • Science and Technology
      •
  41. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-09-13
    Posted: 2012-10-19
    Designated public office holders:
    • Phil Jennings, Associate Assistant Deputy Minister, Industry Canada | Industry Canada
    Subject matters:
    • Science and Technology
      •
  42. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-06-29
    Posted: 2012-07-20
    Designated public office holders:
    • Claude Carignan, Senator | Senate of Canada
    Subject matters:
    • Science and Technology
    • Research and Development
      •
  43. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-06-06
    Posted: 2012-07-20
    Designated public office holders:
    • Jacques Gourde, Member of the House of Commons, House of Commons | House of Commons
    Subject matters:
    • Science and Technology
    • Research and Development
      •
  44. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-05-30
    Posted: 2012-06-20
    Designated public office holders:
    • Pierre Claude Nolin, Senator, Senate | Senate of Canada
    Subject matters:
    • Research and Development
    • Science and Technology
      •
  45. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-05-23
    Posted: 2012-07-20
    Designated public office holders:
    • Barbara Sabourin, Director General, Director General's Office | Health Canada (HC)
    • John Patrick Stewart, Acting Senior Executive Director, Director General's Office | Health Canada (HC)
    Subject matters:
    • Health
      •
  46. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-05-15
    Posted: 2012-06-20
    Designated public office holders:
    • Rob Merrifield, Member of Parliament, House of Commons | House of Commons
    Subject matters:
    • International Trade
      •
  47. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-04-24
    Posted: 2012-06-01
    Designated public office holders:
    • Jacques Gourde, Député, Chambre des communes | House of Commons
    Subject matters:
    • Industry
    • Science and Technology
      •
  48. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-04-04
    Posted: 2012-06-01
    Designated public office holders:
    • François Lapointe, Député, Chambre des Communes | House of Commons
    Subject matters:
    • Science and Technology
    • Industry
      •
  49. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-03-29
    Posted: 2012-04-27
    Designated public office holders:
    • Pierre Claude Nolin, Sénateur, Sénat du Canada | Senate of Canada
    Subject matters:
    • Science and Technology
    • Research and Development
      •
  50. sanofi-aventis Canada Inc.
    Type: In-house Corporation
    Occurred: 2012-01-26
    Posted: 2012-02-17
    Designated public office holders:
    • Stephen Harper, Premier Ministre | Prime Minister's Office (PMO)
    Subject matters:
    • Science and Technology
      •
Date Modified: